{
  "issue_1_baseline_icp": {
    "current_model": 13.9,
    "expected": 28.0,
    "status": "LOW"
  },
  "issue_2_acz_sensitivity": {
    "current_model": -0.7,
    "expected": -3.7,
    "error_mmHg": 3.0,
    "status": "UNDERPREDICTED"
  },
  "issue_3_hsd11b1_pathway": {
    "required_strength": "40-50% NKA amplification",
    "current_prior": "30% (too weak)",
    "status": "CRITICALLY_WEAK"
  },
  "root_causes": [
    "Baseline ICP too low (need higher Rcsf or baseline CSF production)",
    "Treatment effects on CSF production insufficient",
    "11\u03b2-HSD1\u2192NKA pathway severely underpowered (need 40-50% vs 30% prior)",
    "May need nonlinear compliance/ICP relationship for larger dynamic range"
  ],
  "required_fixes": [
    "Increase baseline Rcsf prior: 14\u00b13 mmHg/(mL/min) vs current 10\u00b13",
    "Strengthen ACZ CA inhibition prior: 50\u00b110% vs current weaker Beta",
    "Strengthen 11\u03b2-HSD1\u2192NKA prior: 45\u00b110% vs current 30\u00b110%",
    "Verify transporter fractions sum properly and have correct weights"
  ]
}